Cargando…
Anticancer peptide Q7 suppresses the growth and migration of human endometrial cancer by inhibiting DHCR24 expression and modulating the AKT-mediated pathway
Endometrial cancer is one of the most common malignancy affecting women in developed countries. Resection uterus or lesion area is usually the first option for a simple and efficient therapy. Therefore, it is necessary to find a new therapeutic drug to reduce surgery areas to preserve fertility. Ant...
Autores principales: | Chen, Chia-Hung, Weng, Tzu-Hsiang, Huang, Kai-Yao, Kao, Hui-Ju, Liao, Kuang-Wen, Weng, Shun-Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724248/ https://www.ncbi.nlm.nih.gov/pubmed/36483599 http://dx.doi.org/10.7150/ijms.78349 |
Ejemplares similares
-
Identification of subtypes of anticancer peptides based on sequential features and physicochemical properties
por: Huang, Kai-Yao, et al.
Publicado: (2021) -
Cholesterol Synthetase DHCR24 Induced by Insulin Aggravates Cancer Invasion and Progesterone Resistance in Endometrial Carcinoma
por: Dai, Miao, et al.
Publicado: (2017) -
Dhcr24 activates the PI3K/Akt/HKII pathway and protects against dilated cardiomyopathy in mice
por: Dong, Wei, et al.
Publicado: (2018) -
DHCR24 exerts neuroprotection upon inflammation-induced neuronal death
por: Martiskainen, Henna, et al.
Publicado: (2017) -
Identification and Characterization of 24-Dehydrocholesterol Reductase (DHCR24) in the Two-Spotted Cricket, Gryllus bimaculatus
por: Mack, Yin Shan Isa, et al.
Publicado: (2021)